The sensitivity of the Denver II in identifying developmental delay was. The results of infants that had both a Denver II and a BSID III were assessed.
The study population consisted of both normal and high 10 risk neonates born between 1 July 2013 and 31 December 2015. This is a retrospective descriptive study. The Bayley Scales of Infant and Toddler Development III (BSID III) is used as a gold standard test, to determine the level of agreement between the two tests.
This article aims at assessing the accuracy of the Denver II in identifying developmental delay 6 in high risk newborns. The Denver Developmental Screening Test II (Denver II) is used to assess the development of high risk newborns at a tertiary hospital in Johannesburg.
